repligen corp said intends file investigational new drug application food and drug administration seeking permission test its aids vaccine humans early summer repligen said human tests could end year sufficiently encouraged and impressed work date ahead with clinical trial said michael egan manager business development for repligen biotechnology company repligen egan said vaccine contains subfragment protein coat aids virus animal tests which included primates egan said vaccine provoked neutralizing antibodies aids virus and broader cellular immunity egan said approach repligen using deliver its vaccine using standard vaccine methods may safer vaccines using live smallpox virus carry proteins found surface coat aids virus yesterday bristol myers said would seek regulatory permission test its aids vaccine which uses smallpox virus humans end month repligen aids vaccine collaborative effort company centocor inc duke university medical school and national cancer insitutes research teams directed john ghrayeb centocor scott putney repligen dani bolognesi duke and robert gallo and flossie wong staal national cancer institute although several aids vaccine candidates experts believe development safe and effective vaccine long ways away moreover seeking approval test vaccine only first step long process verifying vaccine actually will prevent infection reuter 